Geneseeq Technology Revenue

Biotechnology Research • Toronto, Ontario, Canada • 21-50 Employees

Geneseeq Technology revenue & valuation

Annual revenue	$2,737,760
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$8,800,000
Total funding	$114,500,000

Key Contacts at Geneseeq Technology

Shanshan Yang

Director, Cancer Screening

Ruoying Yu

Director, Medical Affairs

Jason Du

Director Of International Marketing

Yedan Chen

Associate Director, Global Business Development

Jiyu Yao

Global Sales Marketing Director

Company overview

Headquarters	393 University Avenue, Suite 1802, Toronto, Ontario M5G 1E6, CA
Phone number	+18003620325
Website	geneseeq.com
Keywords	Companion Diagnostics, Precision Medicine, Next Generation Sequencing, Cancer Genomics, Comprehensive Genomic Profiling
Founded	2012
Employees	21-50
Socials

Geneseeq Technology Email Formats

Geneseeq Technology uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@geneseeq.com), used 96.3% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@geneseeq.com	96.3%
{first initial}.{last name}	j.doe@geneseeq.com	3.7%

About Geneseeq Technology

Geneseeq Technology Inc. is a research-driven global leader in precision oncology, advancing cancer detection, diagnosis, and treatment through cutting-edge next-generation sequencing (NGS) technologies. With headquarters in Canada and China, Geneseeq operates CAP-, CLIA-, and ISO 15189-accredited laboratories for central laboratory testing, and is ISO 13485-certified for the development and manufacturing of both in vitro diagnostic (IVD) and research use only (RUO) testing kits. Our comprehensive testing portfolio includes: -Pan-cancer panels covering over 400 genes; -Cancer-type-specific panels tailored for solid tumors and hematologic malignancies; -Minimal residual disease (MRD) monitoring technologies; -Multi-cancer early detection (MCED) solutions, including CanScan®, which holds both CE mark and FDA Breakthrough Device Designation; -CE-IVD and NMPA-approved NGS-based assays, including tumor mutational burden (TMB) testing. Geneseeq’s testing services and products are widely adopted by more than 8,000 oncologist partners across 20+ countries and regions. We are actively involved in over 2,700 research collaborations with pharmaceutical and academic partners, providing high-quality genomic data to support biomarker discovery, clinical development, and translational research. Driven by innovation and a commitment to quality, Geneseeq delivers integrated NGS solutions that help guide personalized treatment decisions and accelerate the global adoption of precision cancer care.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Director

Employees by Department

Geneseeq Technology has 15 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Geneseeq Technology's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-01-25	7	$114,500,000

Funding Insights

$114,500,000

Total funding amount

$114,500,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Geneseeq Technology is located in Toronto, Ontario, CA.

You can reach Geneseeq Technology at +18003620325.

Geneseeq Technology generates an estimated annual revenue of $2,737,760. This revenue figure reflects the company's market position and business performance in its industry.

Geneseeq Technology has an estimated valuation of $8,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Geneseeq Technology was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

Geneseeq Technology has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Geneseeq Technology has raised a total of $114,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.